A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study, Followed by Open-label Extensions, to Evaluate the Efficacy of Oral Belumosudil in Adult Participants With Chronic Lung Allograft Dysfunction (CLAD) Following Bilateral Lung Transplantation
At 74 years of age, Kelowna, B.C. resident Carol Purves has regained her rhythm after losing her husband and true love, Ken, in 2019. Accessing a plethora of community services available to her and gaining friendships along the way, Purves has built a community of support that continues to nurture her mind and body.
“I decided to take advantage of every opportunity that comes my way in my senior years,” says Purves.
A novel longitudinal outreach program for people with opioid use disorder (OUD), set into motion in the emergency department at Vancouver General Hospital, was associated with better health outcomes. Led by Vancouver Coastal Health Research Institute researcher and emergency room physician, Dr. Andrew Kestler, the outreach program resulted in greater participant housing, retention in substance use care and initiation of opioid agonist therapy.
Vancouver Coastal Health Research Institute (VCHRI) facilitates clinician-scientists in their efforts to make new discoveries to improve the health and well-being of patients across their lifespan. The Investigator Awards provide salary support to leading health research investigators to help reduce their clinical commitments and expand their capacity for innovation-driven research that creates new health care knowledge.
The 2024 VCHRI Investigator Awards recipients are:
Irritable bowel syndrome (IBS) is an intestinal disorder affecting about 11 per cent of the global population. Canada is one of the countries with the highest prevalence of IBS in the world at an estimated 18 per cent. Vancouver Coastal Health Research Institute (VCHRI) neurogastroenterologist Dr. Sarvee Moosavi strives to increase awareness about this growing area and educate both clinicians and patients around the signs, symptoms and treatment approaches for IBS.
The emergency department’s role in providing life-saving care can extend into longer-term treatment plans for people with opioid use disorder (OUD). Vancouver Coastal Health Research Institute researcher Dr. Jessica Moe and clinical pharmacy specialist Dr. Katherin Badke researched emergency department health care worker perceptions on connecting people with OUD to the first-line treatment, buprenorphine/naloxone (Suboxone).
Artificial intelligence (AI) applications are revolutionizing health diagnostics and precision medicine, yet how they identify patterns of disease in layers of data has largely remained a mystery. Research led by Vancouver Coastal Health Research Institute researcher Dr.
